Journal ArticleDOI
Neurofeedback with anxiety and affective disorders.
Reads0
Chats0
TLDR
In this paper, a review of neurophysiologic research on functional brain abnormalities associated with depression, anxiety, and obsessive-compulsive disorder is presented, including electroencephalographic (EEG) biofeedback (neurofeedback) for retraining abnormal brain wave patterns.About:
This article is published in Child and Adolescent Psychiatric Clinics of North America.The article was published on 2005-01-01. It has received 200 citations till now. The article focuses on the topics: Anxiety & Neurofeedback.read more
Citations
More filters
Journal ArticleDOI
Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms
TL;DR: Cognitive therapy and antidepressant medication probably engage some similar neural mechanisms, as well as mechanisms that are distinctive to each, which might one day be used to guide treatment selection and improve outcomes.
Journal ArticleDOI
Neurobehavioral Therapies in the 21st Century: Summary of an Emerging Field and an Extended Example of Cognitive Control Training for Depression
TL;DR: The promise of a new generation of therapies targeted to address neurobiological mechanisms thought to underlie psychological disorders, particularly depression, using cognitive and behavioral techniques is discussed in this article.
Journal ArticleDOI
Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings.
TL;DR: This review provides an overview of methods which are frequently used to assess heartbeat perception in clinical studies and summarizes presently available results referring to interoceptive sensitivity with respect to heartbeat in anxiety-related traits (anxiety sensitivity, state/trait anxiety), panic disorder and other anxiety disorders.
Journal ArticleDOI
Self-regulation of regional cortical activity using real-time fMRI: the right inferior frontal gyrus and linguistic processing.
Giuseppina Rota,Giuseppina Rota,Ranganatha Sitaram,Ralf Veit,Ralf Veit,Michael Erb,Nikolaus Weiskopf,Nikolaus Weiskopf,Grzegorz Dogil,Niels Birbaumer,Niels Birbaumer +10 more
TL;DR: The present study confirms the efficacy of fMRI‐biofeedback for noninvasive self‐regulation of circumscribed brain activity and supports a role for the right IFG in the processing of emotional information and evaluation of affective salience.
Journal ArticleDOI
What is Neurofeedback: An Update
TL;DR: In this paper, the authors provide an overview of the field of neurofeedback (EEG biofeedback) and discuss potential risks, side effects, and adverse reactions with guidelines for selecting a legitimately qualified practitioner.
References
More filters
Journal ArticleDOI
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Wayne K. Goodman,Lawrence H. Price,Steven A. Rasmussen,Carolyn M. Mazure,Roberta L. Fleischmann,Candy L. Hill,George R. Heninger,Dennis S. Charney +7 more
TL;DR: In a study involving four raters and 40 patients with obsessive-compulsive disorder at various stages of treatment, interrater reliability for the total Yale-Brown Scale score and each of the 10 individual items was excellent, with high degree of internal consistency among all item scores demonstrated with Cronbach's alpha coefficient.
Journal ArticleDOI
Randomized, controlled trials, observational studies, and the hierarchy of research designs.
TL;DR: The results of well-designed observational studies (with either a cohort or a case-control design) do not systematically overestimate the magnitude of the effects of treatment as compared with those in randomized, controlled trials on the same topic.
Journal ArticleDOI
Defining Empirically Supported Therapies
TL;DR: It is suggested that, in evaluating the benefits of a given treatment, the greatest weight should be given to efficacy trials but that these trials should be followed by research on effectiveness in clinical settings and with various populations and by cost-effectiveness research.
Journal ArticleDOI
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Wayne K. Goodman,Lawrence H. Price,Steven A. Rasmussen,Carolyn M. Mazure,Pedro L. Delgado,George R. Heninger,Dennis S. Charney +6 more
TL;DR: Results from a previously reported placebo-controlled trial of fluvoxamine in 42 patients with obsessive-compulsive disorder showed that the Yale- Brown Scale was sensitive to drug-induced changes and that reductions in Yale-Brown Scale scores specifically reflected improvement in obsessive- compulsive disorder symptoms.
Journal ArticleDOI
The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency
Suck Won Kim,Maurice W. Dysken,Alfred M. Pheley,Alfred M. Pheley,Kathleen Maxwell Hoover,Kathleen Maxwell Hoover +5 more
TL;DR: Examination of the postreatment factor scores showed that the Y-BOCS resistance items did not assess OCD symptom change as sensitively as the rest of the Y, Brown Obsessive-Compulsive Scale items did.